![]() |
市场调查报告书
商品编码
1986783
麻醉用二氧化碳吸收剂市场报告:按产品、类型、最终用户和地区划分(2026-2034 年)Anesthesia CO2 Absorbent Market Report by Product (Soda Lime, Medisorb, Dragersorb, Amsorb, Litholyme, and Others), Type (Premium, Traditional), End User (Hospitals, Clinics, and Others), and Region 2026-2034 |
||||||
2025年,全球麻醉用二氧化碳吸收剂市场规模达8,740万美元。展望未来,IMARC集团预测,到2034年,该市场规模将达到1.368亿美元,2026年至2034年的复合年增长率(CAGR)为4.96%。医院和诊所手术量的不断增加推动了对可靠吸收剂的需求,从而促进了市场成长。
对环保解决方案的需求日益增长
随着环境问题的日益关注,医疗专业人员越来越倾向于选择能够最大限度地减少有害副作用的二氧化碳吸收剂。此外,环保吸收剂能够降低麻醉程序对环境的影响,并与医院的永续性目标相契合,从而推广安全有效的替代方案,在确保有效患者照护的同时,为营造更健康的环境做出贡献。例如,根据贝尔医疗公司(Bell Medical Inc.)2024年5月发表的报导,不含氢氧化钠的「amsorb plus」二氧化碳吸收剂透过防止有害副产物的产生并实现低新鲜气体流量,从而促进了环境友善麻醉。这不仅减少了麻醉剂污染,提高了永续性,也扩大了麻醉用二氧化碳吸收剂的市场规模。
低流量麻醉技术的进展
向低流量麻醉技术的转变能够改善患者预后并减少气体浪费。此外,支援这些技术的二氧化碳吸收器创新使医生能够在较低的新鲜气体流量下维持有效的通气,从而优化资源利用并确保手术环境中的高效气体管理。例如,2024年8月,Penlon推出了配备吸收器和二氧化碳监测功能的E-Flo 6C麻醉机。这透过先进的通气控制和全面的气体监测系统,提高了低流量麻醉的安全性和精确性。根据麻醉二氧化碳吸收器的市场细分,这是一个重要的成长驱动因素。
改进二氧化碳吸收系统的集成
麻醉机二氧化碳吸收功能的日益整合简化了操作,并减少了组件间的多重连接。因此,组装更快,使用更方便。这使得麻醉程序的管理更加高效,同时确保最佳的二氧化碳吸收性能,尤其是在关键的麻醉环境中。例如,飞利浦于2024年10月推出了Siesta i Whispa麻醉机,这是一款整合式呼吸系统(IBS),配备上升式气囊和二氧化碳吸收器。这款创新产品简化了设备与患者的连接,缩短了设定时间,并提高了清洁效率。
The global anesthesia CO2 absorbent market size reached USD 87.4 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 136.8 Million by 2034, exhibiting a growth rate (CAGR) of 4.96% during 2026-2034. The increasing number of surgeries across hospitals and clinics is raising the demand for reliable absorbents, which is stimulating the market.
Growing Demand for Eco-Friendly Solutions
Healthcare providers are increasingly seeking CO2 absorbents that minimize harmful side effects, as environmental concerns are growing. In addition, eco-friendly absorbents reduce the ecological footprint of anesthesia practices and align with sustainability initiatives within hospitals, thereby promoting safer alternatives that contribute to a healthier environment while maintaining effective patient care. For instance, in May 2024, according to an article published by Bell Medical Inc., the sodium hydroxide-free amsorb plus CO2 absorbent is promoting eco-friendly anesthesia by preventing harmful byproducts, and enabling low fresh gas flow techniques, thereby reducing anesthetic agent pollution, improving sustainability, and elevating anesthesia CO2 absorbent market scope.
Advancements in Low-Flow Anesthesia Technologies
The rising shift towards low-flow anesthesia techniques enhances patient outcomes and reduces wasteful gas usage. Moreover, innovations in CO2 absorbents that support these technologies facilitate doctors to maintain effective ventilation with lower fresh gas flows, thereby optimizing resource utilization and ensuring efficient gas management in surgical environments. For instance, in August 2024, Penlon launched the E-Flo 6C anesthesia machine, featuring absorber and CO2 monitoring, thereby enhancing safety and precision in low-flow anesthesia through advanced ventilation control and comprehensive gas monitoring systems. As per the anesthesia CO2 absorbent market segmentation, this is acting as a significant growth-inducing factor.
Improved Integration of CO2 Absorption Systems
Enhanced integration of CO2 absorption within anesthesia machines simplifies the operational setup, reducing the need for multiple connections between components. In contrast, this leads to faster assembly and improved usability, making it simpler to manage anesthesia procedures efficiently while ensuring optimal CO2 absorption performance, particularly in critical anesthesia environments. For instance, in October 2024, Philips introduced the Siesta i Whispa anesthesia machine, an integrated breathing system (IBS) with an ascending bag-in-bottle and CO2 absorber. This innovation streamlines connections between the machine and patient, reducing setup time and improving cleaning efficiency.
Medisorb currently hold the largest anesthesia CO2 absorbent market share
Medisorb exhibits a clear dominance in the market due to its efficient CO2 absorption capabilities, which enhance patient safety during procedures. For example, Medisorb EF was launched to minimize compound formation, thereby ensuring better anesthesia care while reducing environmental impact in medical settings.
Premium currently holds the largest anesthesia CO2 absorbent market demand
The premium segment dominates the market due to its high efficiency, longer-lasting performance, and superior safety features. For example, Drager launched its premium product 'Dragersorb' with enhanced CO2 absorption capabilities, which reduces the risk of compound A formation, ensuring patient safety during anesthesia procedures.
Hospital exhibits the largest anesthesia CO2 absorbent market outlook
Hospitals lead the market as the primary end users, driven by the need for efficient patient care during surgeries. For example, GE Healthcare launched Aisys CS2, an advanced anesthesia machine incorporating CO2 absorbents to enhance safety and reduce environmental impact.
North America currently dominates the market
The anesthesia CO2 absorbent market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
As per the anesthesia CO2 absorbent market overview, North America dominates the market, which is driven by well-established healthcare systems, high surgical volumes, and innovative advancements. In addition, the region's dominance is also supported by growing awareness of patient safety and effective waste gas management during surgeries. For example, Drager launched its 'Dragersorb Free' absorbent, a CO2 absorbent designed to prevent the formation of toxic compounds during anesthesia. Furthermore, such innovations highlight North America's role in advancing safe and efficient anesthesia practices.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all market companies have also been provided. Some of the key players in the market include:
()